Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Student performers dazzle at Kovsie Extravaganza
2014-10-01

The Kovsie Extravaganza is an annual highlight on our university’s Arts and Culture calendar. The event offers outstanding Kovsie artists the opportunity to showcase their talent in music, dance and poetry – to name but a few – live on stage. The Sand d u Plessis theatre in Bloemfontein was packed to capacity for this highly-anticipated performance on 27 September 2014.

With the multi-award winning a cappella trio, The Soil, and Kovsie Idol Delia Moumakwe included in the line-up, tickets were already sold out nine hours before the show.

But the Kovsie acts by no means paled in comparison to these stars. In addition, the Free State Youth Orchestra – which includes some of the most talented students at our Odeion School of Music – provided an inspired performance.

This full production had the crowd dancing, cheering and clapping throughout the ecvent. The size and reaction of the audience was firm proof of the Kovsie Extravaganza’s growing popularity.

Speaking to Ntsika Ngxanga, a member of The Soil, he said that they were truly blessed to have made it this far in the music industry. Growing up in Soweto in difficult circumstances, the trio is now performing on stages across the globe. “We thank the UFS for their support towards the extravaganza. We definitely wish the student community all the best with their studies. Education is important,” Ngxanga said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept